General Information (Schedule Of Unaudited pro forma operation results) (Details) (USD $)	3 Months Ended		83 Months Ended	12 Months Ended
	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2013	Dec. 31, 2012 Genetic Immunity, Inc
Net Sales
Cost of Sales			3,711
Gross margin			2,122
Material expenses	24,903	4,150	136,504	68,406
General administration	155,467	133,820	8,311,724	1,482,366
Research and development			824,807
Personnel expenses	140,778	23,034	835,268	724,264
Depreciation and amortization	37,179	21,312	599,241	191,427
Grants received				518,631
Other expenses, net	3	13	22,086	347,448
Operating expenses	329,548	182,329	10,574,065	2,295,280
Loss from operations	(329,548)	(182,329)	(10,571,943)	(2,295,280)
Interest income and exchange gains	548,879		(59,661)	(279,982)
Loss before income taxes	127,711	(191,095)	(10,891,955)	(2,575,262)
Income taxes			3,192	(1,985)
Net loss				$ (2,577,247)